Another place to seek out potentially explosive stocks is in the biotech space. These innovators are working on the ...

Sales of Casgevy, a gene-edited treatment developed with CRISPR Therapeutics, more than tripled compared to the third quarter, a performance analysts saw as a bright spot in Vertex's report.

Researchers developed a CRISPR-based system that spreads through bacterial populations to disable antibiotic resistance genes ...

Researchers at Texas A&M are pairing a widely used ingredient with advanced medical technology to develop new treatments for ...

A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.

Researchers used CRISPR gene editing to selectively kill cancer cells with amplified oncogenes. In animal and cellular models ...

A new highly sensitive light-based sensor can detect extremely low concentrations of cancer biomarkers in the blood.

ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial ...

A novel CRISPR-based technology can spread within bacterial populations to eliminate antibiotic resistance.

CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025. "As we ...

Active Genetics (Pro-AG) exploits a naturally created bacterial mating tunnel between cells to inactivate antibiotic resistance.